Most of the bio companies ARK invests in are US-based, and we do not believe tariffs will impact them. In fact, we view recent tariff policies as a tailwind accelerating the growth of the US biotech footprint. Research Analyst Nemo Marjanovic, PhD discusses our biotech strategy in this askARK.
Similar Posts
Clearing Up WWII Battlefields – Gathering Weapons & Kit
Who cleared WW2 battlefields of all the weapons and soldiers’ kit that was left strewn about…
‘Not in charge’: Trump mocked for ‘cognitive deficiencies’ in revealing Oval Office moment
President Donald Trump has signed more than 150 executive orders, often with cameras rolling and staff…
Thailand, Cambodia vow to fight on as border clashes force thousands to flee
Tens of thousands of people have been displaced by renewed fighting along the Thailand-Cambodia border.That’s as…
CEO of sole American smartphone manufacturer has bad news for Trump’s new phone company
Earlier this week, the Trump Organization (President Donald Trump’s family-run business) unveiled its latest business venture…
Google loses online ad monopoly case. But it’s just one of many antitrust battles against big tech
The Department of Justice argued Google used exclusionary agreements, such as paying Apple billions annually to…
One year after Trump’s inauguration, US–Africa policy has changed fundamentally • FRANCE 24
In tonight’s edition, one year after Donald Trump took office in the White House, has Washington…
